House committee votes for amendment in market protection of biotech drugs
스크롤 이동 상태바
House committee votes for amendment in market protection of biotech drugs
기자명
메디칼라이터팀
입력 2009.08.04 00:00
수정 2009.08.04 09:57
댓글 0
The House Energy and Commerce Committee voted in favor of allowing 12 years of market protection to high-tech drugs used to combat cancer, Parkinson"s and other deadly diseases adding the amendment to broader healthcare legislation making its way through Congress. Mr. Obama and some Democrats, including the energy committee chairman, Rep. Henry Waxman (D-CA) hoped to give patients faster access to cheaper generic versions of biotech medicines therefore reducing the country"s healthcare costs.